CDK9 inhibitors in acute myeloid leukemia

Current treatment for acute myeloid leukemia (AML) is less than optimal, but increased understanding of disease pathobiology and genomics has led to clinical investigation of novel targeted therapies and ratio...

from Cancer via ola Kala on Inoreader http://ift.tt/2GE6X3k
via IFTTT